Perillaldehyde Mitigates Ionizing Radiation‐Induced Intestinal Injury by Inhibiting Ferroptosis via the Nrf2 Signaling Pathway

ScopeGastrointestinal toxicity is one of the major side effects of abdominopelvic tumor radiotherapy. Studies have shown that perillaldehyde (PAH) has antioxidant, antiinflammatory, antimicrobial activity, and antitumor effects. This study aims to determine whether PAH has radioprotective effects on...

Full description

Saved in:
Bibliographic Details
Published in:Molecular nutrition & food research 2023-10, Vol.67 (19), p.e2300232-e2300232
Main Authors: Tang, Lin‐Feng, Ma, Xiaoming, Xie, Li‐Wei, Zhou, Hao, Yu, Jiahua, Wang, Zhen‐Xin, Li, Ming
Format: Article
Language:English
Subjects:
Anticancer properties
Antimicrobial activity
Antioxidants
Antitumor activity
Crypts
DNA damage
Epithelial cells
Epithelium
Ferroptosis
Injuries
Intestine
Ionizing radiation
Irradiation
Organoids
Radiation
Radiation damage
Radiation protection
Radiation therapy
Side effects
Signal transduction
Survival
Toxicity
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ScopeGastrointestinal toxicity is one of the major side effects of abdominopelvic tumor radiotherapy. Studies have shown that perillaldehyde (PAH) has antioxidant, antiinflammatory, antimicrobial activity, and antitumor effects. This study aims to determine whether PAH has radioprotective effects on radiation‐induced intestinal injury and explore the underlying mechanisms.Methods and resultsC57BL/6J mice are gavaged with PAH for 7 days, then exposed to a single dose of 13 Gy X‐ray total abdominal irradiation (TAI). PAH treatment prolongs the survival time, promotes the survival of crypt cells, attenuates radiation‐induced DNA damage, and mitigates intestinal barrier damage in the irradiated mice. PAH also shows radioprotective effects in intestinal crypt organoids and human intestinal epithelial cells (HIEC‐6). PAH‐mediated radioprotection is associated with the upregulation of nuclear factor erythroid‐2 related factor 2 (Nrf2), activation of the antioxidant pathway, and inhibition of ferroptosis. Notably, treatment with the Nrf2 inhibitor ML385 abolishes the protective effects of PAH, indicating that Nrf2 activation is essential for PAH activity.ConclusionPAH inhibits ionizing radiation (IR)‐induced ferroptosis and attenuates intestinal injury after irradiation by activating Nrf2 signaling. Therefore, PAH is a promising therapeutic strategy for IR‐induced intestinal injury.
ISSN:1613-4125
1613-4133
DOI:10.1002/mnfr.202300232